United Therapeutics (UTHR) CEO trades 9,500 shares under 10b5-1 plan
Martine A. Rothblatt, Chairperson & CEO of United Therapeutics (UTHR), exercised 9,500 stock options at $135.42 per share and subsequently sold these 9,500 common shares in open-market transactions ranging from $523 to $539 per share on August 10, 2026. This activity was conducted under …